Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
about
Decreased plasma fibronectin concentrations in preterm infants with septicaemia.Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.Reticuloendothelial function in coeliac disease and ulcerative colitis.Diagnosing malnutrition.Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.Fibronectin in fulminant hepatic failure.Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin.Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation.Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growthFibronectin as an opsonic regulator of monocyte phagocytosis.Fibronectin: applications to clinical medicine.Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.Fibronectin binding to protein A-containing staphylococci.Plasma fibronectin is initially decreased during septicemia.Symposium report blood culture--current state and future prospects. Abstracts
P2860
Q33623347-627B081B-5274-4CBD-81ED-6640A5A82A3BQ33832980-DC9C631E-4095-43A0-8232-4FBB2779DF89Q34495892-03ABA6A1-F9E3-4383-8061-EA405A0EEF26Q34533419-45BAB7C1-63C7-4B9D-BA7A-BD3EE8EDDA1CQ34598422-2C6EDE4C-286E-4C2A-92EB-1B7525A11010Q34764037-3D4FDFFC-A938-45DF-9FCD-DB0B10E7AF68Q35380896-C6B0DF7D-49D7-4EDE-809A-60445A542219Q35815945-5ED9CD63-C01A-4DAD-A9AF-E5D5CEE8F673Q36044047-C71FD0B8-9A90-4377-B650-15848C5993C6Q39529491-81947C17-4BAF-4A33-B07D-9E101CAEA698Q39727785-C31AD5F0-08FC-4C52-AB3C-BAD4C14426D8Q40597978-EBB78682-5260-45F1-A880-3F6ACBCA7468Q40611648-2547AD48-AA2E-445E-8B83-2F1E14DF6698Q44979205-6F30A8F6-96F5-436B-BB7E-68CBC5E53E8EQ57657165-75F353EE-B0B7-405D-AB95-BBA5FB695F14
P2860
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh-hant
name
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@en
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@nl
type
label
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@en
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@nl
prefLabel
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@en
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@nl
P2093
P2860
P1433
P1476
Opsonic alpha2 surface binding glycoprotein therapy during sepsis.
@en
P2093
Blumenstock FA
Powers SR Jr
Scovill WA
P2860
P304
P356
10.1097/00000658-197810000-00009
P407
P577
1978-10-01T00:00:00Z